Long Term Clinical Results in Axillofemoral Bypass for Aortoiliac Occlusive Disease, Especially in Terms of QOL.

Long-term outcome of aortofemoral bypass for aortoiliac occlusive disease.

INTRODUCTION Revascularisation of aortoiliac occlusive disease has been evolving in the past 2 decades. The present study was undertaken to evaluate the long-term outcomes of aortofemoral bypass for aortoiliac occlusive disease at a tertiary vascular disease centre in Hong Kong. MATERIALS AND METHODS A retrospective analysis of 94 patients (176 limbs) who survived aortofemoral bypass was perf...

Ten year outcomes after bypass surgery in aortoiliac occlusive disease

PURPOSE Most outcome studies of bypass surgery are limited to five years of follow-up. However, as human life expectancy has increased, analyses of more long-term outcomes are needed. The aim of this study is to evaluate 10-year outcomes of anatomical bypasses in aortoiliac occlusive disease. METHODS From 1996 to 2009, 92 patients (82 males and 10 females) underwent aortic anatomical bypasses...

Experimental laparoscopic aortobifemoral bypass for occlusive aortoiliac disease.

OBJECTIVE To describe a totally laparoscopic technique for aortobifemoral bypass to treat aortoiliac atheromatous occlusive disease. DESIGN A feasibility study. SETTING A university teaching hospital. SUBJECTS Six piglets weighing between 70 and 80 kg were submitted to a totally laparoscopic retroperitoneal aortobifemoral bypass, performed through six trocar sites, with abdominal suspensi...

Mid-term results of robot-assisted laparoscopic surgery for aortoiliac occlusive disease.

The aim of this study was to evaluate middle-term clinical results of robot-assisted laparoscopic surgery (RALS) to treat aortoiliac occlusive disease (AIOD). Between 2002 and 2007, 28 consecutive patients received robot-assisted laparoscopic aortobifemoral bypass grafting (n = 24) or aortoiliac endarterectomy (n = 4). Patients were followed prospectively. RALS could be completed successfully i...

Groningen Covered stents in aortoiliac occlusive disease